GSK Plc (GSK)
53.34
+0.87
(+1.66%)
USD |
NYSE |
Feb 03, 16:00
54.67
+1.33
(+2.49%)
Pre-Market: 04:27
GSK Shareholders Equity (Quarterly) : 21.74B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 45.89B |
| Mereo BioPharma Group Plc | 46.60M |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | -29.42M |
| NuCana Plc | 34.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.58B |
| Total Liabilities (Quarterly) | 61.37B |
| Debt to Equity Ratio | 1.099 |
| Current Ratio | 0.8363 |
| Net Debt Paydown Yield | -0.57% |